Viewing Study NCT02567851


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-25 @ 9:35 PM
Study NCT ID: NCT02567851
Status: COMPLETED
Last Update Posted: 2018-05-11
First Post: 2015-09-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity
Sponsor: University of Birmingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module